Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Clin Oncol. Oct 10, 2014; 5(4): 677-692
Published online Oct 10, 2014. doi: 10.5306/wjco.v5.i4.677
Figure 4
Figure 4 Comparison of selective and non-selective cyclooxygenase-2 inhibitors in cancer prevention. Bars represent 95%CI of each estimate[101].